ReviewMolecular cancer2018

Mechanisms of rapid cancer cell reprogramming initiated by targeted receptor tyrosine kinase inhibitors and inherent therapeutic vulnerabilities.

Emily K Kleczko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.